— Know what they know.
Not Investment Advice
Also trades as: IDIA.SW (SIX) · $vol 8M · 0RQE.L (LSE) · $vol 5M

IDRSF OTC

Idorsia Ltd
1W: +1.5% 1M: -13.9% 3M: -32.8% YTD: +2.5% 1Y: +17.0% 3Y: -40.2% 5Y: -80.7%
$5.38
-0.02 (-0.37%)
 
Weekly Expected Move ±5.6%
$5 $5 $5 $6 $6
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 38 · $1.4B mcap · 195M float · 0.0016% daily turnover · Short 91% of daily vol

Income Trends

Revenue
$221M +96.5% ▲
5Y CAGR: +25.2%
Gross Profit
$200M +160.7% ▲
Operating Income
-$116M +49.8% ▲
Net Income
-$112M +57.5% ▲
EPS (Diluted)
$-0.52 +64.1% ▲
EBITDA
-$45M +79.8% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$35M$97M$152M$113M$221M
YoY Growth-50.7%+174.7%+56.9%-26.2%+96.5%
Cost of Revenue$18M$6M$7M$36M$21M
Gross Profit$17M$91M$145M$77M$200M
Gross Margin49.0%93.5%95.3%68.1%90.3%
R&D Expenses$414M$383M$294M$144M$0
SG&A Expenses$234M$507M$393M$273M$221M
Operating Expenses$648M$894M$400M$309M$316M
Operating Income-$613M-$803M-$255M-$232M-$116M
Operating Margin-1734.1%-826.9%-167.4%-206.2%-52.6%
Interest Expense$28M$17M$21M$20M$43M
Income Before Tax-$635M-$820M-$294M-$263M-$106M
Tax Expense-$210K$8M$4M$434K$6M
Net Income-$635M-$828M-$298M-$264M-$112M
Net Margin-1795.2%-852.6%-195.5%-234.4%-50.7%
EPS (Diluted)$-3.77$-4.67$-1.67$-1.45$-0.52
EBITDA-$589M-$783M-$255M-$225M-$45M
Shares Outstanding168M177M178M182M215M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms